XYL
33
2
MAT
45
2
HSIC
48
3
YUM
45
2
ZION
56
4
XRX
57
-2
PAYX
54
9
FOX
70
-3
PLD
45
5
MSI
55
-2
BWA
45
3
FMC
20
-2
EOG
30
-2
MS
72
2
KHC
13
-2
SYK
55
-2
SBUX
39
3
ZTS
43
3
WBA
44
6
MNST
59
7
XYL
33
2
MAT
45
2
HSIC
48
3
YUM
45
2
ZION
56
4
XRX
57
-2
PAYX
54
9
FOX
70
-3
PLD
45
5
MSI
55
-2
BWA
45
3
FMC
20
-2
EOG
30
-2
MS
72
2
KHC
13
-2
SYK
55
-2
SBUX
39
3
ZTS
43
3
WBA
44
6
MNST
59
7
Financhill
Back

Regeneron Pharmaceuticals Vs. Aligos Therapeutics Industry Stock Comparison

Sell
45

REGN
Regeneron Pharmaceuticals

Last Price:
$714.54
Seasonality Move:
9.99%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$40.50
Seasonality Move:
-16.03%
Sell
45
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $716.68. The Score for REGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $716.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -27.19 Sell
Relative Strength Index (14 RSI): 34.69 Sell
Chaikin Money Flow: 377563 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (720.58 - 766.88) Sell
Bollinger Bands (100): (789.67 - 1133.55) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 716.99 Sell
20-day SMA: 743.24 Sell
50-day SMA: 808.56 Sell
200-day SMA: 977.12 Sell
8-day EMA: 720.58 Sell
20-day EMA: 741.69 Sell
50-day EMA: 811.56 Sell
200-day EMA: 927.94 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.14 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):